CXT: the cashflow

MyFinsight

For the quarter ending 2025-09-30, CXT had $30,300K increase in cash & cash equivalents over the period.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net income before allocation to noncontrolling interest	50,900	46,700
Stock-based compensation expense	3,300	6,000
Deferred income taxes	1,100	-12,800
Other	1,500	3,200
Accounts receivable	-600	-900
Inventories	9,700	7,900
Other current assets	3,200	9,900
Accounts payable	12,900	-23,800
Accrued liabilities	-8,100	11,900
U.s. and foreign taxes on income	13,700	-19,300
Cash used for operating working capital	-6,200	48,100
Depreciation and amortization	29,000	48,700
Total provided by operating activities	92,000	43,700
Amount paid, net of cash acquired	-2,900	394,000
Capital expenditures	13,300	20,100
Settlement of forward contracts	300	1,500
Total used for investing activities	-10,100	-412,600
Dividends paid	9,700	19,500
Proceeds from stock options exercised	900	1,300
Payment of tax withholding on equity awards vested	100	5,800
Debt issuance costs	3,500	800
Proceeds from revolving credit facility	36,500	348,000
Repayment of revolving credit facility	71,500	342,000
Proceeds from term loan	0	400,400
Repayment of term loan	4,100	36,800
Total provided by financing activities	-51,500	344,800
Effect of exchange rates on cash, cash equivalents and restricted cash	-100	15,200
Increase (decrease) in cash, cash equivalents and restricted cash	30,300	-8,900
Cash and cash equivalents at beginning of period	173,400	-
Cash and cash equivalents at end of period	194,800	-

Unit: Thousand (K) dollars